NCT03810781

Brief Summary

Veterans are at heightened risk of developing cervical spondylotic myelopathy (CSM) from rigors of military service. Balance and posturography are negatively affected in CSM, but require expensive equipment, and extensive training of personnel for data acquisition and interpretation. The Virtual Environment TBI Screen (VETS) is a simple and inexpensive construct that could be implemented as an aid in diagnosis and as an objective means to compare treatment modalities and track recovery. The goal for the SPiRE is to generate the critical data to support rigorous Merit studies of posturography for assessments of clinical course in the treatment and rehabilitation of CSM. The investigators' ultimate goal, if the SPiRE is successful, is to phase in objective posturography assessments as VA standard of care in CSM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 22, 2019

Completed
16 days until next milestone

Study Start

First participant enrolled

February 7, 2019

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
3.3 years until next milestone

Results Posted

Study results publicly available

December 15, 2025

Completed
Last Updated

December 15, 2025

Status Verified

November 1, 2025

Enrollment Period

3.6 years

First QC Date

January 16, 2019

Results QC Date

March 18, 2024

Last Update Submit

November 26, 2025

Conditions

Keywords

PosturographySpinal Cord Injury

Outcome Measures

Primary Outcomes (2)

  • Virtual Environment TBI System (VETS) Assessment of Static Posturography

    The postural stability task involves six conditions during which Veterans are instructed to look straight ahead and maintain an upright stance as stably as possible. Veterans are barefooted with feet comfortably placed \~25 cm apart. The six conditions are (1) Eyes Open (EO) Firm (2) Eyes Closed (EC) Firm, (3) Dynamic Scene (DYN) Firm, (4) EO Foam, (5) EC Foam, and (6) DYN Foam. a) Comparison of CSM vs. Control and within-subject visual (EO,EC, and DYN) and surface conditions (FIRM and FOAM). b) Comparison of balance and posture at Pre-surgery for CSM group to age and gender matched non-CSM controls. Only pre-surgery data in CSM group was collected due to COVID-19.

    Pre-Surgery compared to otherwise healthy Veterans

  • Change in Static Posturography (VETS)

    The Pre-surgery CSM group recruited for VETS (Static Posturography) measurement will also serve as the sample for the change in VETS measurement as a change in centimeters (cm). This is a longitudinal assessment of balance following surgical intervention for CSM.

    Pre-surgery compared to 2 weeks, 6 weeks, and 6 months post-surgery VETS factors. The Post-surgery endpoints are normally scheduled clinical follow ups.

Secondary Outcomes (8)

  • Nurick Scale

    PreSurgery compared to otherwise healthy Veterans

  • Neck Disability Index (NDI)

    PreSurgery compared to otherwise healthy Veterans

  • Short Form-36 Version 2 (SF-36v2)

    PreSurgery compared to otherwise healthy Veterans

  • EC FIRM/EO FIRM Ratio

    PreSurgery

  • EO FOAM/EO FIRM

    PreSurgery compared to otherwise healthy Veterans

  • +3 more secondary outcomes

Study Arms (1)

Cervical Spondylotic Myelopathy (CSM)

Degenerative cervical myelopathy, encapsulates a cascade of events leading to significant degenerative changes in discs, formation of osteophytes, facet hypertrophy, calcification of the posterior longitudinal ligament and ligamentous flavum with resultant canal stenosis and segmental instability.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

US Veterans.

You may qualify if:

  • symptoms of myelopathy in upper and lower extremities and stenosis of the cervical spine demonstrated by MRI or myelography
  • lower extremity muscle strength of 4 as quantified by manual muscle test (MMT) 36 or above
  • ability to stand without support with eyes closed for 30 s or more
  • Veterans in the control group will be recruited from the SVAMC and surrounding community using printed advertisements

You may not qualify if:

  • presence of lower extremity or lumbar spine disease
  • peripheral neuropathy
  • history of other neurological disorder
  • inability to stand in an upright position with both feet together and eyes closed
  • Although the SVAMC population is predominately Caucasian and male, every effort will be made to recruit minorities and women
  • The proposed study will neither target for recruitment nor will the investigators exclude pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Syracuse VA Medical Center, Syracuse, NY

Syracuse, New York, 13210, United States

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Limitations and Caveats

COVID significantly disrupted our ability to complete the study. Scheduling for CSM surgery was drastically impacted by COVID and never returned to Pre-COVID format. Some subjects recruited before COVID could not be followed up due to a ban on research. We were also unable to recruit controls because our VA only permitted research appointments for individuals who were already coming to the VA for a medical appointment (e.g. surgical follow-up).

Results Point of Contact

Title
Dr. Richard Servatius
Organization
Syracuse VA Medical Center

Study Officials

  • Richard J. Servatius, PhD

    Syracuse VA Medical Center, Syracuse, NY

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2019

First Posted

January 22, 2019

Study Start

February 7, 2019

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

December 15, 2025

Results First Posted

December 15, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations